PINL:CRFTF - Post by User
Post by
HawkIIon Jun 24, 2019 9:21am
![](https://assets.stockhouse.com/kentico-cms/0341-00/images/Sprite.svg#id_Post_Views_Icon)
157 Views
Post# 29855263
CRFTy press releases
CRFTy press releasesWhat a great deal for shareholders ... NOT!. Today's news about CBD Therapeutics is old and already known from CRFT's Listing Statement on SEDAR, specifically (pg 7) "On November 7, 2018, Pasha completed the acquisition of all of the issued and outstanding share capital of 1160899 B.C. Ltd. (d/b/a CBD Therapeutics)" and (pg 135) "As consideration, the Company has the following commitments ... iii. 50,000,000 common shares of the Company at the date of closing (issued)". The acquisition was $14mm (cash +shares) + $1.4mm in finder common shares, which seems a lot for a business that is described in their MD&A as a business that "did not have inputs, processes and outputs in place that constituted a business under IFRS3".